Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L. Hauser, Ludwig Kappos, Amit Bar‐Or et al.|New England Journal of Medicine|2020Cited by 706
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trialFred Lublin, Ludwig Kappos, David H. Miller et al.|The Lancet|2016Cited by 449
AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding studyFabrizio Stocchi, Claudia Trenkwalder, Werner Poewe et al.|Movement Disorders|2013Cited by 137